China's AustAsia Swings to Profit in H1, Aided by Lower Feed Costs and Higher Beef Prices

China's HeartCare Medical H1 Revenue Surges on Stroke Segment Growth

Tong Ren Tang Technologies Inks E-Commerce Framework Agreement with Tong Ren Tang Digital Technology

Chinese Traditional Medicine Maker Tong Ren Tang Profit Falls on Weaker Demand

Tong Ren Tang Chinese Medicine Wins Hong Kong Registration for Sanzi Yangqin Keli Product

Tong Ren Tang Technologies Signs New E-Commerce Services Deal with Tong Ren Tang Shuzi Technology Through 2028

Tong Ren Tang Tech FY26 H1 Profit Attributable to Owners Drops 26.43% to RMB 249.14 Million; Revenue Falls 19.1% to RMB 3.02 Billion

Community Wellness Initiative Extended at Beijing Tong Ren Tang Liu Jiayao Outlet Through Mid-September

Tong Ren Tang Technologies Schedules Board Meeting on Interim Results, Dividend Decision

Tong Ren Tang Tech Names Mei Zhe Joint Company Secretary, Board Secretary, Authorized Representative

Tongrentang Gets Canada's Product License for Shiyi Qingwen Pills

TONGRENTANGCARE Makes Stock Market Debut with Shares Falling Sharely

Top Eminent Healthcare Appoints Wang Yinqing as Executive Director Effective July 1

Tong Ren Tang Tech declares final dividend of RMB 0.18 per share for FY2025

Beijing Tong Ren Tang Receives Canadian Production Site Certification and Product Approval

Tong Ren Tang's $105 Million Acquisition Deal Falls Through: Hurdles in Healthcare Market Expansion Add Uncertainty to Channel Transformation

Tongrentang's Subsidiary Drops Honghui Pharma Acquisition

Tongrentang's Cachet Pharmaceutical Takeover Clears Antitrust Review

Tong Ren Tang Technologies wins Hong Kong registration for Antelope Horn Powder Capsules

Tongrentang's Subsidiary Secures Hong Kong Registration for Traditional Chinese Medicine Product